Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2000-3-30
pubmed:abstractText
Recombinant technology was used to produce a new anticoagulant that is preferentially localized and active at the site of the clot.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1524-4539
pubmed:author
pubmed:issnType
Electronic
pubmed:day
14
pubmed:volume
101
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1158-64
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
2000
pubmed:articleTitle
Construction and functional evaluation of a single-chain antibody fusion protein with fibrin targeting and thrombin inhibition after activation by factor Xa.
pubmed:affiliation
Department of Cardiology, University of Freiburg, Freiburg, Germany. peter@mm31.ukl.uni-freiberg.de
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't